Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
NovoCure
NVCR
$2.06B
| $57.3M | 0.01% |
680,315
+77,381
| +13% | +$6.25M |
|
852
Manulife Financial
MFC
$73.4B
| $57.3M | 0.01% |
2,814,107
+288,933
| +11% | +$5.52M |
|
853
Howard Hughes
HHH
$3.94B
| $57.3M | 0.01% |
473,821
+17,146
| +4% | +$1.9M |
|
854
RLJ Lodging Trust
RLJ
$1.69B
| $57.2M | 0.01% |
3,227,302
+43,660
| +1% | +$742K |
|
855
Exponent
EXPO
$3.18B
| $57.2M | 0.01% |
828,673
+31,065
| +4% | +$2.05M |
|
856
KBR
KBR
$4.76B
| $57.1M | 0.01% |
1,872,465
-2,816
| -0.2% | -$79.2K |
|
|
PACW
857
DELISTED
PacWest Bancorp
PACW
| $57M | 0.01% |
1,490,358
+82,285
| +6% | +$3.09M |
|
858
Chegg
CHGG
$95.6M
| $57M | 0.01% |
1,502,623
+86,782
| +6% | +$3.04M |
|
|
MRTX
859
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $56.9M | 0.01% |
441,493
+11,369
| +3% | +$1.1M |
|
|
CIM
860
Chimera Investment
CIM
$990M
| $56.7M | 0.01% |
912,376
+55,165
| +6% | +$3.37M |
|
861
MongoDB
MDB
$33.9B
| $56.7M | 0.01% |
431,370
+9,472
| +2% | +$1.24M |
|
|
IBKC
862
DELISTED
IBERIABANK Corp
IBKC
| $56.5M | 0.01% |
755,619
-39,136
| -5% | -$2.91M |
|
|
TMX
863
DELISTED
Terminix Global Holdings, Inc.
TMX
| $56.5M | 0.01% |
1,461,456
+54,953
| +4% | +$2.34M |
|
|
SF
864
Stifel
SF
$12.8B
| $56.3M | 0.01% |
2,087,118
+43,751
| +2% | +$1.14M |
|
865
Moog Inc Class A
MOG.A
$13.2B
| $56.2M | 0.01% |
659,125
+26,013
| +4% | +$2.22M |
|
866
Penumbra
PEN
$12.8B
| $56.1M | 0.01% |
341,417
+13,524
| +4% | +$2.15M |
|
867
Madison Square Garden
MSGS
$9.48B
| $56M | 0.01% |
267,042
+11,959
| +5% | +$2.35M |
|
|
BLUE
868
DELISTED
bluebird bio
BLUE
| $55.9M | 0.01% |
49,201
+1,433
| +3% | +$1.56M |
|
869
Pinnacle Financial Partners Inc
PNFP
$15.9B
| $55.8M | 0.01% |
871,582
+34,294
| +4% | +$2.07M |
|
|
LHCG
870
DELISTED
LHC Group LLC
LHCG
| $55.8M | 0.01% |
404,820
+11,249
| +3% | +$1.4M |
|
|
AL
871
DELISTED
Air Lease Corp
AL
| $55.7M | 0.01% |
1,173,023
+39,929
| +4% | +$1.79M |
|
|
PRSP
872
DELISTED
Perspecta Inc. Common Stock
PRSP
| $55.7M | 0.01% |
2,105,221
+133,153
| +7% | +$3.55M |
|
|
NUVA
873
DELISTED
NuVasive, Inc.
NUVA
| $55.6M | 0.01% |
718,733
+20,161
| +3% | +$1.42M |
|
874
Canadian Imperial Bank of Commerce
CM
$110B
| $55.5M | 0.01% |
1,327,758
+183,826
| +16% | +$7.77M |
|
|
BPMC
875
DELISTED
Blueprint Medicines
BPMC
| $55.4M | 0.01% |
691,318
+29,612
| +4% | +$2.22M |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.